In the last trading session, 1.81 million shares of the Regulus Therapeutics Inc (NASDAQ:RGLS) were traded, and its beta was 0.37. Most recently the company’s share price was $7.89, and it changed around -$0.02 or -0.25% from the last close, which brings the market valuation of the company to $546.26M. RGLS currently trades at a discount to its 52-week high of $8.20, offering almost -3.93% off that amount. The share price’s 52-week low was $0.83, which indicates that the current value has risen by an impressive 89.48% since then.
Regulus Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.67. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 4 recommended RGLS as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Regulus Therapeutics Inc (NASDAQ:RGLS) trade information
Instantly RGLS has showed a red trend with a performance of -0.25% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 7.97 on recent trading dayincreased the stock’s daily price by 1.0%. The company’s shares are currently up 399.37% year-to-date, but still up 0.25% over the last five days. On the other hand, Regulus Therapeutics Inc (NASDAQ:RGLS) is 181.79% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to decrease their stock price by -12.71% from its current value. Analyst projections state that RGLS is forecast to be at a low of $7 and a high of $7.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 40.21%. Regulus Therapeutics Inc earnings are expected to increase by -10.57% in 2025, but the outlook is positive 11.89% per year for the next five years.
RGLS Dividends
Regulus Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
RA CAPITAL MANAGEMENT, L.P., with 9.6952% or 6.25 million shares worth $11.16 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 7.88 shares worth $62.18 million, making up 11.38% of all outstanding shares. On the other hand, Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund held roughly 7.42 shares worth around $58.52 million, which represents about 10.71% of the total shares outstanding.
